Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial

Overview of attention for article published in Osteoporosis International, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 3 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 118 Dimensions

Readers on

mendeley: 172 Mendeley

Summary News Blogs X Facebook Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

Stroke Risk Dooms Once-Promising Bone Drug

MedPage Today, 19 Sep 2016

Action Points Note that this study was published as an abstract and presented at a conference.

Odanacatib Lowers Fracture Risk in Some Women

MedPage Today, 14 Oct 2015

Action Points Note that this study was published as an abstract and presented at a conference.